Some New Targets and Approaches to the Construction of Intended-Use Metabiotics

Shenderov, Boris A.; Sinitsa, Alexander V.; Zakharchenko, Mikhail M.; Lang, Christine

doi:10.1007/978-3-030-34167-1_16

Boris A. Shenderov⁵,
Alexander V. Sinitsa⁶,
Mikhail M. Zakharchenko⁶ &
…
Christine Lang⁷

375 Accesses

Abstract

Tables 1, 2, 3, 4, 5, 6, 7 and 8 show some new targets and approaches to the use of low molecular microbial molecules for the development and production of essentially new metabiotics in order to prevent and treat common conditions associated with microecological imbalance in humans. These approaches, if realized, will enable to promptly and efficiently use the potential of the basic representatives of human symbiotic microbiota when creating targeted metabiotics.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Chapter: USD 29.95; Price excludes VAT (USA)

eBook: USD 149.00; Price excludes VAT (USA)

Softcover Book: USD 189.00; Price excludes VAT (USA)

Hardcover Book: USD 199.99; Price excludes VAT (USA)

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

Althaus M, Behnsen J, Deriu E, Sassone-Corci M, Raffatellu M. Probiotics: properties, examples, and specific applications. Cold Spring Perspect Med. 2013;3:a0110074. doi:https://doi.org/10.1101/cshperspect.a010074.
Article CAS Google Scholar
Atkinson S, William P. Quorum sensing and social networking in the microbial world. J Royal Soc Interface. 2009;6(40):959–78. doi:https://doi.org/10.1098/rsif.2009.0203.
Article CAS Google Scholar
Bhat MI, Kapila R. Dietary metabolites derived from gut microbiota: critical modulators of epigenetic changes in mammals. Nutr Rev. 2017;75(1):374–389. doi:https://doi.org/10.1093/nutrit/nux001.
Article PubMed Google Scholar
Blander JM, Longman RS, Iliev ID, Sonnenberg GF, Artis D. Regulation of inflammation by microbiota interactions with the host. Nature Immunology. 2017;18(6):851–860. doi:https://doi.org/10.1038/ni.3780.
Article CAS PubMed PubMed Central Google Scholar
Browne HP, Forster SC, Anonye BO, Kumar N, Neville BA et al. Culturing of “unculturable” human microbiota reveals novel taxa and extensive sporulation. Nature. 2016;533:543–546. doi:https://doi.org/10.1038/nature17645.
Article CAS PubMed PubMed Central Google Scholar
Buffie CG, Pamer EG. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol. 2013;13(11):790–801. doi:https://doi.org/10.1038/nri3535.
Article CAS PubMed PubMed Central Google Scholar
Chernevskaya EA, Beloborodova NV. Gut microbiome in critical illness (Review). General Reanimatology. 2018;14(5):96–119. https://doi.org/10.15360/1813-9779-2018-5-96-119.
Article Google Scholar
Chervinets YuV, Chervinets VM, Shenderov BA. The modern view on the biotechnological potential of human symbiotic microbiota. Upper Volga medical journal. 2018;17(1):19–26 (in Russian).
Google Scholar
Choi SW, Friso S. Epigenetics: A New Bridge between Nutrition and Health. Adv Nutr. 2010;1(1):8–16. doi:https://doi.org/10.3945/an.110.1004.
Article CAS PubMed PubMed Central Google Scholar
Corthesy B, Gaskins HR, Marcenier A. Cross-Talk between Probiotic Bacteria and the Host Immune System. J Nutr. 2007;137:781–790. doi:https://doi.org/10.1093/jn/137.3.781S.
Article Google Scholar
Cyr AR, Hitchler MJ, Domann FE. Regulation of SOD2 in cancer by histone modifications and CpG methylation: closing the loop between redox biology and epigenetics. Antiox Redox Signal. 2013;18(15):1946–1955. doi:https://doi.org/10.1089/ars.2012.4850.
Article CAS Google Scholar
El Aidy S, Stilling RM, Dinan TG, Cryan JT. Microbiome to Brain: Unravelling the multidirectional axes of communication. Adv Exp Med Biol. 2016;874:301–336.
Article PubMed Google Scholar
Engevik MA, Versalovic J. Biochemical feature of beneficial microbes: foundation for therapeutic microbiology. Microbial Spectr. 2017;5(5). doi:https://doi.org/10.1128/microbiolspec.BAD-0012-2016.
Feil R, Fraga MF. Epigenetics and the environment: emerging patterns and implications. Nat Rev Genet. 2012;13:97–109. doi:https://doi.org/10.1038/nrg3142.
Article CAS PubMed Google Scholar
Foster JA, Lyte M, Meyer E, Cryan JF. Gut Microbiota and Brain Function: An Evolving Field in Neuroscience. Int J Neuropsychopharmacol. 2016;19(5):pyv114. doi:https://doi.org/10.1093/ijnp/pyv114.
Article PubMed Central Google Scholar
Ghisian Y, Nana G, Ripoll C, Cabin-Flaman A, Gibouin D, Delaune A et al. Division-Based, Growth Rate Diversity in bacteria. Front Microbiol. 2018;9;849. doi:https://doi.org/10.3389/fmicb.2018.00849.
Jimenez-Chillaron JC, Diaz R, Martinez D, Pentinat T, Ramon-Krauel M, Ribo S, Plosch T. The role of nutrition on epigenetic modifications and their implications on health. Biochimie. 2012;94:2242–2263. doi:https://doi.org/10.1016/j.biochi.2012.06.012.
Article CAS PubMed Google Scholar
Jones RM, Neish AS. Redox signaling mediated by the gut microbiota. Free Radical Biology and Medicine. 2017;105:41–47. doi:https://doi.org/10.1016/j.freeradbiomed.2016.10.495.
Article CAS PubMed Google Scholar
Kamada N, Nunez G. Regulation of the immune system by the resident intestinal bacteria. Gastroenterology. 2014;146(6):1477–1488. doi:https://doi.org/10.1053/j.gastro.2014.01.060.
Article CAS PubMed Google Scholar
Karczewski J, Poniedzialek B, Adamski Z, Rzymski P. The effects of the microbiota on the host immune system. Autoimmunity. 2014;47(8):494–504. doi:https://doi.org/10.3109/08916934.2014.938322.
Article CAS PubMed Google Scholar
Kazerouni A, Burgess J, Burns LJ, Wein LM. Optimal screening and donor management in a public stool bank. Microbiome. 2015;3:75. doi:https://doi.org/10.1186/s40168-015-0140-3.
Article PubMed PubMed Central Google Scholar
Laino J, Villena J, Kanmani P, Kitazawa H. Immunoregulatory effects triggered by lactic acid bacteria exopolysaccharides: new insights into molecular interaction with host cells. Microorganisms. 2016;4:27. doi:https://doi.org/10.3390/microorganisms4030027.
Article CAS PubMed Central Google Scholar
Lebeer S, Bron PA, Marco ML, Van Pijkeren JP, O’Conell Motherway M et al. Identification of probiotic effect or molecules: present state and future perspectives. Curr Opin Biotechnol. 2018;49:217–223. doi:https://doi.org/10.1016/j.copbio.2017.10.007.
Article CAS PubMed Google Scholar
Lebeer S, Vanderleyden J, De Keersmaeker SCJ. Genes and molecules of lactobacilli supporting probiotic action. Microbiol Mol Biol Rev. 2008;72(4):728–764. doi:https://doi.org/10.1128/MMBR.00017-08.
Article CAS PubMed PubMed Central Google Scholar
Legent G, Norris V. Hybolites: novel therapeutic toolsfor targeting hyperstructure in bacteria. Recent Pat on Antiinfect Drug Discov. 2009;4(2):90–95.
Article CAS Google Scholar
Li Y, Tollefsbol TO. Impact on DNA methylation in cancer prevention and therapy by bioactive compounds. Curr Med Chem. 2010; 17(20):2141–2151.
Article PubMed PubMed Central Google Scholar
Maguire M, Maguire G. Gut dysbiosis, leaky gut, and intestinal epithelial proliferation in neurological disorders: towards the development of a new therapeutic using amino acids, prebiotics, probiotics, and postbiotics. Rev Neurosci. 2019;30(2):179–201. doi:https://doi.org/10.1515/revneuro-2018-0024.
Article PubMed Google Scholar
Marco ML, Pavan S, Kleerebezem M. Towards understanding molecular modes of probiotic action. Curr Opin Biotechnol. 2006;17(2):204–210. doi:https://doi.org/10.1016/j.copbio.2006.02.005.
Article CAS PubMed Google Scholar
Matsumoto K, Hara H, Fishov I, Mileykovskaya E, Norris V. The membrane: transertion as an organizing principle in membrane heterogeneity. Front Microbiology. 2015;6:572. doi:https://doi.org/10.3389/fmicb.2015.00572.
Article Google Scholar
Minushkin ON, Ardatskaya MD, Sergeev AV, Volkov MYu, Sinitsa AV. Experience in the use of probiotic «Baktistatin» in the treatment of chronic pancreatitis. Pharmacy. 2006;3:39–43 (in Russian).
Google Scholar
Mischke M, Plosch T. The gut microbiota and their metabolites: Potential implications for the host epigenome. Adv Exp Med Biol. 2016;902:33–44. doi:https://doi.org/10.1007/978-3-319-31248-4_3.
Article PubMed Google Scholar
Mishra V, Shah C, Mokashe N, Chavan R, Yadav H, Prajapati J. Probiotics as potential antioxidants: A systematic review. J. Agric Food Chem. 2015;63(14):3615–3626. doi:https://doi.org/10.1021/jf506326t.
Article CAS PubMed Google Scholar
Ng SC, Harf AL, Kamm MA, Stagg AJ, Knight SC. Mechanism of action on probiotics: recent advances. Inflamm Bowel Dis. 2009;15(2):300–310. doi:https://doi.org/10.1002/ibd.20602.
Article CAS PubMed Google Scholar
Nicolson GL, de Mattos GF, Settineri R, Costa C, Ellithorpe R et al. Clinical effects of hydrogen administration: from animal and human diseases to exercise medicine. Intern J Clin Medicine. 2016;7(1):32–76. doi:https://doi.org/10.4236/ijcm.2016.71005.
Article CAS Google Scholar
Norris V, Verrier C, Feuilloley M. Hybolites Revisited. Recent Pat on Anti-Infect Drug Discov. 2016;11(1):1–13.
Article CAS PubMed Google Scholar
Oleskin AV, El’-Registan GI, Shenderov BA. Role of neuromediators in the functioning of the human microbiota: «business talks» among microorganisms and the microbiota-host dialogue. Microbiology. 2016;85(1):1–22.
Article CAS Google Scholar
Oleskin AV, Shenderov BA, Rogovsky VS. Role of Neurochemicals in the Interaction between the Microbiota and the Immune and the Nervous System of the Host Organism. Probiotics and Antimicrobial Proteins. 2017;9(3):215–234. doi:https://doi.org/10.1007/s12602-017-9262-1.
Article CAS PubMed Google Scholar
Oleskin AV, Shenderov BA. Neuromodulatory effects and targets of the SCFAs and gasotransmitters produced by the human symbiotic microbiota. Microb Ecol Health Dis. 2016;27:30971. doi:https://doi.org/10.3402/mehd.v27.30971.
Article CAS PubMed Google Scholar
Proal AD, Lindseth IA, Marshall TG. Microbe-Microbe and Host-Microbe Interactions Drive Microbiome Dysbiosis and Inflammatory Processes. Discovery Medicine. 2017;23(124):51–60.
PubMed Google Scholar
Prosekov A, Dyshlyuk L, Milentyeva I, Sukhish S, Babich O et al. Antioxidant, antimicrobial and antitumor activity of bacteria of the genus Bifidobacterium, selected from the gastrointestinal tract of human. Integr Mol Med. 2015;2(5):295–303.
Google Scholar
Remely M, Lovrecic L, de la Garza AL, Migliore L, Peterlin B et al. Therapeutic perspectives of epigenetically active nutrients. British J Pharmacol. 2015;172(11):2756–2768. doi:https://doi.org/10.1111/bph.12854.
Article CAS Google Scholar
Roda A, Simoni P, Magliulo M, Nanni P, Baraidini M et al. A new oral formulation for the release of sodium butyrate in the ileo-cecal region and colon. World J Gastroenterol. 2007;13(7):1079–1084. doi:https://doi.org/10.3748/wjg.v13.i7.1079.
Article CAS PubMed PubMed Central Google Scholar
Russell WR, Duncan SH, Scobbie L, Duncan G, Cantlay L et al. Major phenylpropanoid-derived metabolites in the human gut can arise from microbial fermentation of protein. Mol Nutr Food Res. 2013;57(3):523–535. doi:https://doi.org/10.1002/mnfr.201200594.
Article CAS PubMed Google Scholar
Said HM. Recent advances in transport of water-soluble vitamins in organs of the digestive system: a focus on the colon and the pancreas. Am J Physiol Gastrointest Liver Physiol. 2013;305(9):G601–610. doi:https://doi.org/10.1152/ajpgi.00231.2013.
Article CAS PubMed PubMed Central Google Scholar
Sanshez S, Demain AL. Antibiotics: Current Innovations and Future Trends. Caister Academic Press; 2015.
Google Scholar
Savidge TC. Epigenetic Regulation of Enteric Neurotransmission by Gut Bacteria. Front Cell Neurosci. 2015;9:503. doi:https://doi.org/10.3389/fncel.2015.00503.
Article PubMed Google Scholar
Schauder S, Bassler BL. The languages of bacteria. Genes Dev. 2001;15(12):1468–1480.
Article CAS PubMed Google Scholar
Sharma M, Shukla G. Metabiotics: One Step ahead of Probiotics; an Insight into Mechanisms Involved in Anticancerous Effect in Colorectal Cancer. Front. Microbiol. 2016;7:1940. doi:https://doi.org/10.3389/fmicb.2016.01940.
Article PubMed PubMed Central Google Scholar
Shenderov BA, Aleshkin VA. Functional Dairy Foods in Human Epigenetic Regulation. In: Abstract Book IDF WORLD DAIRY SUMMIT. 4–8 November 2012. Cape Town. Poster 0121.
Google Scholar
Shenderov BA, Gakhova EN, Kaurova SA, Uteshev VK, Shishova NV. Cryobanks of natural symbiotic microbiocenosis and their importance in medicine and biotechnology. Biophysics of live cell. 2014;10:221–223 (in Russian).
Google Scholar
Shenderov BA, Manvelova MA, Gahova EN, Piorunski DA. Functional food and cryobanks of microbiocenoses-practical applications of gnotobiology in the 21st century. In: Hashimoto K et al, editors. Germfree life and its ramifications. Japan: Shiozawa; 1996. p. 533–536.
Google Scholar
Shenderov BA, Midtvedt T. Epigenomic programing: a future way to health? Microb Ecol Health Dis. 2014;25:24145. doi:https://doi.org/10.3402/mehd.v25.24145.
Article Google Scholar
Shenderov BA. Functional food, cryobanks of microbial associations and their role in the preservation and restoration of health. Journal of Restorative Medicine & Rehabilitation. 2003;3:29–31 (in Russian).
Google Scholar
Shenderov BA. Metabiotics — novel prophylactic technology of diseases associated with microecological imbalance of human being. Journal of Restorative Medicine & Rehabilitation. 2017;4:40–49 (in Russian).
Google Scholar
Shenderov BA. Modern Condition and Prospective Host Microecology Investigations. Microb Ecol Heath Dis. 2007;19(3):145–149. doi:https://doi.org/10.1080/08910600701520933.
Article Google Scholar
Shenderov BA. Probiotic (symbiotic) bacterial languages. Anaerobe. 2011a;17(6):490–495. doi:https://doi.org/10.1016/j.anaerobe.2011.05.009.
Article CAS PubMed Google Scholar
Shenderov BA. Role of mitochondria in preventive, restorative and sport medicine. Journal of Restorative Medicine & Rehabilitation. 2018;1:21–31 (in Russian).
Google Scholar
Singh A, Vishwakarma V, Singhal B. Metabiotics: The Functional Metabolic Signatures of Probiotics: Current State-of-Art and Future Research Priorities — Metabiotics: Probiotics Effector Molecules. Advan Biosci Biotechnol. 2018;9(4):147–189. doi:https://doi.org/10.4236/abb.2018.94012.
Article CAS Google Scholar
Suvorov A, Karaseva A, Kotyleva M, Kondratenko Y, Lavrenova H et al. Autoprobiotics as an approach for restoration of personalized microbiota. Front Microbiol. 2018;9:1869. doi:https://doi.org/10.3389/fmicb.2018.01869.
Article PubMed PubMed Central Google Scholar
Thellier M, Legent G, Amar P, Norris V, Ripoll C. Steady-state kinetic behavior of functioning-dependent structures. The FEBS journal. 2006;273(18):4287–4299. doi:https://doi.org/10.1111/j.1742-4658.2006.05425.x.
Article CAS PubMed Google Scholar
Thompson JA, Oliveira RA, Djukovic A, Ubeda C, Xavier KB. Manipulation of the Quorum-Sensing Signal AI-2 Affects the Antibiotic-Treated Gut Microbiota. Cell Reports. 2015;10(11):1861–71. doi:https://doi.org/10.1016/j.celrep.2015.02.049.
Article CAS PubMed Google Scholar
Vakhitov TYa, Petrov LN, Bondarenko VM. The concept of a probiotic drug containing original microbial metabolites. Zh Mikrobiol (Moscow). 2005; 5:108–114 (in Russian).
Google Scholar
Venema K, do Carmo AP. Probiotic and Prebiotics: Current Research and Future Trends. Wageningen: Caiser Academic Press; 2015. doi:https://doi.org/10.21775/9781910190098.
Verbeke F, De Craemer S, Debunne N, Janssens Y, Wynendaele E. Peptides as Quorum Sensing Molecules: Measurement Techniques and Obtained Levels In vitro and In vivo. Front Neurosci. 2017;11:183. doi:https://doi.org/10.3389/fnins.2017.00183.
Article PubMed PubMed Central Google Scholar
Volkov MYu, Tkachenko EI, Vorobeichikov EV, Sinitsa AV. Bacillus subtilis metabolites as a novel promising probiotic preparations. Zh Mikrobiol (Moscow). 2007;2:75–80 (in Russian).
Google Scholar
Wallace BD, Redinbo MT. The Human Microbiome is a Source of Therapeutic Drug Targets. Curr Opin Chem Biol. 2013;17(3):379–384. doi:https://doi.org/10.1016/j.cbpa.2013.04.011.
Article CAS PubMed PubMed Central Google Scholar
Wallace DC. The epigenome and the mitochondrion: bioenergetics and the environment. Gen Dev. 2010;24(15):1571–1573. doi:https://doi.org/10.1101/gad.1960210.
Article CAS Google Scholar
Zhernakova A, Kurilshikov A, Bonder MJ, Tigchelaar EF, Schirmer M et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science. 2016;352(6285):565–569. doi:https://doi.org/10.1126/science.aad3369.
Article CAS PubMed PubMed Central Google Scholar

Download references

Author information

Authors and Affiliations

Research Laboratory for Design & Implementation of Personalized Nutrition-Related Product & Diets, K.G. Razumovsky University of Technology & Management, Moscow, Russia
Boris A. Shenderov
Kraft Ltd., St. Petersburg, Russia
Alexander V. Sinitsa & Mikhail M. Zakharchenko
MBCC Group, Berlin, Germany
Christine Lang

Authors

Boris A. Shenderov
View author publications
You can also search for this author in PubMed Google Scholar
Alexander V. Sinitsa
View author publications
You can also search for this author in PubMed Google Scholar
Mikhail M. Zakharchenko
View author publications
You can also search for this author in PubMed Google Scholar
Christine Lang
View author publications
You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

About this chapter

Cite this chapter

Shenderov, B.A., Sinitsa, A.V., Zakharchenko, M.M., Lang, C. (2020). Some New Targets and Approaches to the Construction of Intended-Use Metabiotics. In: METABIOTICS. Springer, Cham. https://doi.org/10.1007/978-3-030-34167-1_16

Download citation

DOI: https://doi.org/10.1007/978-3-030-34167-1_16
Published: 14 February 2020
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-34166-4
Online ISBN: 978-3-030-34167-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)

Publish with us

Policies and ethics